Drug firm Alembic Pharmaceuticals on Friday reported a 81.15 per cent rise in its consolidatednet profit to Rs 224.63 crore for March quarter mainly on account of robust sales.
The company had posted a net profit of Rs 124 crore for the corresponding period of previous fiscal, Alembic Pharmaceuticals said in a filing to the BSE.
Consolidatedrevenue from operations of the company stood at Rs 1,206.83 crore for the quarter under considerationas against Rs 926.95 crore for the same period year ago, it added.
For the fiscal year 2019-20, the company posted a net profit of Rs828.82 crore as against Rs 584.37 crore for 2018-19,Alembic Pharmaceuticals said.
The consolidated revenue from operations for the fiscal ended March 2020 stood at Rs 4,605.75 crore. It was Rs 3,934.68 crore for FY19, it added.
Shares of Alembic Pharmaceuticals closed at Rs897.50per scrip on the BSE, down 0.02 per cent over previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app